Details for New Drug Application (NDA): 065123
✉ Email this page to a colleague
The generic ingredient in MUPIROCIN is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 065123
Tradename: | MUPIROCIN |
Applicant: | Padagis Israel |
Ingredient: | mupirocin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 065123
Mechanism of Action | RNA Synthetase Inhibitors |
Medical Subject Heading (MeSH) Categories for 065123
Suppliers and Packaging for NDA: 065123
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 065123 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-112 | 45802-112-14 | 1 TUBE in 1 CARTON (45802-112-14) / 15 g in 1 TUBE |
MUPIROCIN | mupirocin | OINTMENT;TOPICAL | 065123 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-112 | 45802-112-22 | 1 TUBE in 1 CARTON (45802-112-22) / 22 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 2% | ||||
Approval Date: | Nov 7, 2003 | TE: | AB | RLD: | No |
Complete Access Available with Subscription